Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAR342434 vs Humalog in Type 1 Diabetes
NCT02273180Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2014
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 8
01
Overview
A Phase 3 trial of insulin lispro in type 1 diabetes mellitus (T1D), sponsored by Sanofi. Started Oct 2014; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02273180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02273180.